About: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.26 (-5.47%)
IMMX NASDAQ Immix Biopharma Inc
Loading watchlist status…
Immix Biopharma Inc share price
IMMX price activity
Last Price
$7.260
Change (24hr)
-0.42 USD (5.47%)
Volume
1.51M
Volume (4w avg)
-
Open
$7.65
Day Range
$7.18 - $7.91
Previous Close
$7.68
Last Trade
02 Nov, 9:28 pm GMT+0
Delayed
02 Nov, 9:28 pm GMT+0
IMMX price performance
-10.65%
5D
-25.00%
1M
+38.81%
YTD
+99.45%
1Y
Delayed
02 Nov, 9:28 pm GMT+0
IMMX details
IMMX Market Signals